BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 19669839)

  • 1. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.
    Murphy MM; Simons JP; Ng SC; McDade TP; Smith JK; Shah SA; Zhou Z; Earle CC; Tseng JF
    Ann Surg Oncol; 2009 Nov; 16(11):2968-77. PubMed ID: 19669839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual treatment disparities after oncology referral for rectal cancer.
    Morris AM; Billingsley KG; Hayanga AJ; Matthews B; Baldwin LM; Birkmeyer JD
    J Natl Cancer Inst; 2008 May; 100(10):738-44. PubMed ID: 18477800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial disparity in consultation, treatment, and the impact on survival in metastatic colorectal cancer.
    Simpson DR; Martínez ME; Gupta S; Hattangadi-Gluth J; Mell LK; Heestand G; Fanta P; Ramamoorthy S; Le QT; Murphy JD
    J Natl Cancer Inst; 2013 Dec; 105(23):1814-20. PubMed ID: 24231453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis.
    Singal V; Singal AK; Kuo YF
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):715-22. PubMed ID: 22246279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer.
    Nipp R; Tramontano AC; Kong CY; Pandharipande P; Dowling EC; Schrag D; Hur C
    Cancer Med; 2018 Feb; 7(2):525-535. PubMed ID: 29322643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma.
    Murphy MM; Simons JP; Hill JS; McDade TP; Chau Ng S; Whalen GF; Shah SA; Harrison LH; Tseng JF
    Cancer; 2009 Sep; 115(17):3979-90. PubMed ID: 19514091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival.
    Heller DR; Nicolson NG; Ahuja N; Khan S; Kunstman JW
    JAMA Surg; 2020 Feb; 155(2):e195047. PubMed ID: 31800002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study.
    Zhou H; Zhang Y; Wei X; Yang K; Tan W; Qiu Z; Li S; Chen Q; Song Y; Gao S
    Cancer Med; 2017 Nov; 6(11):2745-2756. PubMed ID: 28980417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial disparities in treatment and survival of male breast cancer.
    Crew KD; Neugut AI; Wang X; Jacobson JS; Grann VR; Raptis G; Hershman DL
    J Clin Oncol; 2007 Mar; 25(9):1089-98. PubMed ID: 17369572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial disparities in esophageal cancer treatment and outcomes.
    Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; McGinn TG; Wisnivesky JP
    Ann Surg Oncol; 2008 Mar; 15(3):881-8. PubMed ID: 17987341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tracking and feedback registry to reduce racial disparities in breast cancer care.
    Bickell NA; Shastri K; Fei K; Oluwole S; Godfrey H; Hiotis K; Srinivasan A; Guth AA
    J Natl Cancer Inst; 2008 Dec; 100(23):1717-23. PubMed ID: 19033569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-institutional study of pancreatic cancer in Harris County, Texas: race predicts treatment and survival.
    Wray CJ; Castro-Echeverry E; Silberfein EJ; Ko TC; Kao LS
    Ann Surg Oncol; 2012 Sep; 19(9):2776-81. PubMed ID: 22526908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States.
    Tavakkoli A; Singal AG; Waljee AK; Elmunzer BJ; Pruitt SL; McKey T; Rubenstein JH; Scheiman JM; Murphy CC
    Clin Gastroenterol Hepatol; 2020 Jan; 18(1):171-178.e10. PubMed ID: 31202981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial Differences in Treatment and Survival among Veterans and Non-Veterans with Stage I NSCLC: An Evaluation of Veterans Affairs and SEER-Medicare Populations.
    Williams CD; Alpert N; Redding TS; Bullard AJ; Flores RM; Kelley MJ; Taioli E
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):112-118. PubMed ID: 31624076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process.
    Riall TS; Townsend CM; Kuo YF; Freeman JL; Goodwin JS
    Cancer; 2010 Feb; 116(4):930-9. PubMed ID: 20052726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial disparities in esophageal cancer outcomes.
    Revels SL; Morris AM; Reddy RM; Akateh C; Wong SL
    Ann Surg Oncol; 2013 Apr; 20(4):1136-41. PubMed ID: 23263780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in racial disparities in pancreatic cancer surgery.
    Shah A; Chao KS; Ostbye T; Castleberry AW; Pietrobon R; Gloor B; Clary BM; White RR; Worni M
    J Gastrointest Surg; 2013 Nov; 17(11):1897-906. PubMed ID: 24002757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California.
    Zell JA; Rhee JM; Ziogas A; Lipkin SM; Anton-Culver H
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):546-52. PubMed ID: 17372250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
    Yothers G; Sargent DJ; Wolmark N; Goldberg RM; O'Connell MJ; Benedetti JK; Saltz LB; Dignam JJ; Blackstock AW;
    J Natl Cancer Inst; 2011 Oct; 103(20):1498-506. PubMed ID: 21997132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial differences in brain cancer characteristics and survival: an analysis of SEER data.
    Bytnar JA; Lin J; Shriver CD; Zhu K
    Cancer Causes Control; 2019 Dec; 30(12):1283-1291. PubMed ID: 31641915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.